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NTRODUCTION Meningococcal Meningitis and Associated Serogroups Meningococcal meningitis caused by Neisseria meningitidis is currently an important health problem in both developed and developing countries. In the latter, estimates of 330,000 cases annually result in 35,000 deaths (172) . This gram-negative diplococcus is a specific human pathogen, although it is possible to induce the disease in monkeys by intraspinal injection of pure cultures (180) . Virulent strains, i.e., those that have been isolated from the bloodstream or cerebrospinal fluid, are invariably capsulated. This capsule surrounds each organism and enables it to avoid host defenses (124) . Infection is spread by droplets in suspension, and the dispersion of the microbe is followed by colonization of the nasopharynx. The carrier state is relatively common (5 to 10% depending on the season) and only occasionally progresses to symptomatic disease (15, 124) .
The organism can cause a variety of clinical syndromes ranging from fulminating septicemia with septic shock and little or no meningitis, multiple organ failure, and death to the other extreme of only a benign meningococcemia and various types of arthritis described as being associated with meningococcal infection (186) . The most habitual presentation is meningitis, the commonest form of which is produced by invasion of the bloodstream by the meningococcus across the blood-brain barrier (the meninges). The organisms are then capable of multiplying in the cerebrospinal fluid, causing cerebral inflammation that often leads to mental retardation or death. The mechanism by which the disease progresses from an asymptomatic carrier state to invasive infection is unknown. This is partly due to the lack of a suitable animal model in which the various stages of human disease can be reproduced. Various animal species, including monkeys, guinea pigs, rabbits, rats, mice, and chicken embryos, have been used in the study of meningococcal pathogenesis (17) . The models of intraperitoneal infection in mice and in newborn rats have been widely used in studies of passive protection in group B meningococcal vaccine evaluations (185, 224) . Although these models have the advantage of simplicity, they are inadequate for reproducing the route of infection in humans. Recently, a model of intranasal infection of newborn mice has been developed, but even though it more closely approximates the natural route, this model is still a limited one for the study of meningitis (131). Predisposing factors to disease development such as influenza virus infection (92, 170) or the failure to secrete blood group substances of the ABO system (28, 240) have been identified from epidemiological data. The course of the disease can be very rapid, from the appearance of striking symptoms or diagnosis to death within 24 h.
Three species of organisms, N. meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, cause approximately 75% of the cases of bacterial meningitis and share the common characteristic of having polysaccharide capsules that play a fundamental role in pathogenesis (28) . The N. meningitidis capsule is made up of high-molecular-weight anionic polysaccharides that form the basis of the serological classification of the species into distinct serogroups: A, B, C, 29-E, H, I, K, L, W-135, X, Y, and Z (19, 201) . Meningococcal disease is an endemic as well as worldwide epidemic illness. The endemic form has an incidence of one to five cases per 100,000 population anually, while epidemics with peaks of 500 cases per 100,000 have occurred (124) . Although the proportion of meningococcal disease caused by individual serogroups varies among countries, more than 95% is caused by strains of serogroups A, B, C, Y, and W-135 (224) . More than 90% of the strains isolated from patients belong to serogroups A, B, and C, and group B alone accounts for 50 to 70% of the cases. Serogroups X, Z, and 29-E are only rarely associated with disease, and patients with infections caused by strains of these serogroups generally have some form of immunodeficiency (100) . A (195, 219) .
Substantial evidence exists supporting the unique role of the complement system in the prevention of meningococcal disease (44, 45, (150, 190) , whereas in the latter, they cannot assemble the membrane attack complex and express complement-dependent bactericidal activity (13 (173, 225, 228) . In Spain, serogroup B is responsible for endemic meningitis in Galicia and has been the predominant serogroup in the last epidemic waves (91% of the cases in the 1980 epidemic) (58, 180) .
Meningococcal vaccines against the A and C serogroups were developed at the end of the 1960s (80, 230) . These were made of high-molecular-weight purified polysaccharides derived from each organism group. This polysaccharide is a linear homopolymer which, in the case of group A, is made up of 0-acetylated residues in the 3 position of mannosamine-6-phosphate linked o(1-6) and, in the case of group C, is a linear homopolymer made up of 0-acetylated residues in position 7 and/or 8 (in O-acetyl-positive form) or made up of nonacetylated (O-acetyl-negative) N-acetyl neuraminic acid linked ct (2) (3) (4) (5) (6) (7) (8) (9) . The efficiency and safety of these vaccines have been demonstrated in a number of controlled field trials and in epidemics, although the vaccine is ineffective in children under age 2 (group C) or in infants under 6 months of age (group A), and the long-term protective effects of vaccination with a combined group A and C polysaccharide vaccine have been unsatisfactory (37, 41 (206, 207) , are generally present in most N. meningitidis serotypes, but they may be absent. Considerable variation in their level of expression exists, and the expression rate can sometimes be reduced during the course of an infection (66, 107 (18, 152) . Initially, these epitopes appeared to be linear in nature and inaccessible to specific antibodies in the intact cells of some strains (227) , but the most recent studies using cyclic peptides point to the conformational nature of the class 1 epitopes (39) . Although antibodies to class 1 proteins were protective in the newborn rat model mentioned above, this protection appeared to be type specific (185) .
Class 5 proteins, which are analogous to gonococcal protein II, are modified by heat in a characteristic manner. Proteins solubilized at 37°C migrate faster in SDS-polyacrylamide gel electrophoresis (PAGE) than those solubilized at 100°C (6) .
These class 5 proteins show not only interstrain heterogeneity but also two types of intrastrain variability: (i) phase variation in levels of expression; and (ii) antigenic variations, i.e., simultaneous expression of multiple proteins. Up to four different variants of class 5 proteins have been observed in a single strain of N. meningitidis, and a single strain can simultaneously express none to four of them (2) . Specific bactericidal antibodies against exposed surface epitopes of class 5 are perhaps too specific to be considered relevant for their inclusion in a hypothetical vaccine.
Recently, a new OMP has been described, termed class Sc (3, 57) . Of similar molecular weight to the rest of the class 5 proteins, it bears only weak sequence homology to the others but has a conserved interstrain sequence. An important role in the invasion and colonization of the epithelial mucosa has been suggested for this protein (219) . Specific human monoclonal antibodies show bactericidal activity against meningococcal strains that express high protein Sc levels but fail to do so with the laboratory strain B385 (57). Most virulent meningococcal isolates are probably not susceptible to this mechanism of killing, because they express only small or undetectable amounts of 5c (174) .
The class 4 protein appears to be very stable and conserved in all meningococcal strains. It bears considerable homology to gonococcal protein III and to a portion of the OMP, OmpA, of Escherichia coli. Monoclonal antibodies directed against protein III also react with the class 4 protein; however, not only do these have no bactericidal activity, but they inhibit the bactericidal effect mediated by antibodies directed against other outer membrane antigens (147) .
IRPs
Iron-regulated proteins (IRPs) are another important component of the meningococcal outer membrane. The ability of a bacterial pathogen to acquire iron is critical for pathogenesis, and the meningococcus is no exception. An example is the increased lethality of meningococci in a murine infection model after the administration of iron-containing compounds (38) . The availability of inorganic iron in the human host is extremely low (144) . Among the main iron sources are hemoglobin and the iron transport proteins, transferrin and lactoferrin (21) . The majority of bacterial pathogens use siderophores, soluble low-molecular-weight chelating agents that can compete with host iron-binding proteins and internalize the iron after they bind to membrane receptors (144, 164) . N. meningitidis seems incapable of synthesizing siderophores but sequesters iron directly from transferrin (21, 58, 84) , lactoferrin (164) , and hemoglobin (120) by receptor-mediated processes. These receptors are OMPs inducible under ironlimiting conditions, i.e., IRPs.
While the lactoferrin binding protein has been identified as an IRP of 105 kDa specific for human lactoferrin, the transferrin binding proteins (TBPs), also with human specificity (8) , are very heterogeneous in both size and antigenicity (58, 84) . A TBP1 with a molecular mass of 98 kDa which cannot bind transferrin after SDS-PAGE has been described, as has a TBP2 of molecular mass 68 to 85 kDa which can bind human transferrin after SDS-PAGE and electroblotting. Previously, a 70-to 71-kDa protein that was not identical to TBP2 (149, 164, 182) and a 36-to 37-kDa protein denominated major-IRP which also seemed to bind transferrin had been described (144) . Recently, a hemoglobin-binding protein exposed on the bacterial surface and which appears not to be serogroup specific has been identified (120). However, unlike other IRPs, it can bind to both human and bovine proteins, suggesting that the heme fraction is the ligand being recognized.
Studies of the antigenicity and immunogenicity of IRPs have mainly been based on the transferrin receptors. Analysis of the 70-kDa protein indicates that it might be possible to elicit bactericidal antibodies that are highly strain specific, pointing to the antigenic variability of the exposed epitopes (164) . TBP2 has considerable molecular heterogeneity, but common antigenic domains have been shown in TBP2s of N. meningitidis strains and even N. gonorrhoeae and H. influenzae type b; however, no data regarding how these epitopes are exposed in the intact organism are available (199) . In this context, it has been demonstrated that in vivo the human transferrin receptor is expressed on the meningococcal surface (7) . Antibodies that block iron acquisition could potentially be protective without the need for complement-dependent bactericidal activity (239) .
LOS
Some nonprotein components of the outer membrane of gram-negative bacteria are glycosylated, thus enabling interaction of the organism with the aqueous environment. The glycolipids of the enterobacteria, which live in a bile acid-rich environment, are called LPS, the hallmark of gram-negative organisms, and consist of three structural domains. The outermost one is the 0-specific polysaccharide or 0 antigen (156), which is long, hydrophilic, and neutral. It is made up of repetitive oligosaccharide (OS) units and carries the main serological specificity. It helps to prevent dispersion of the bacterial lipid membranes by the bile acids (82) . The 0-specific polysaccharide is linked to a central OS, which in turn is linked to a basal glycolipid (lipid A) anchored in the outer membrane and associated with the biological effects of LPS (endotoxin) toxicity that usually accompanies the bacteremia due to gramnegative organisms (156, 168) . The glycolipids of Neisseria spp., along with those of other bacteria that colonize mucosal surfaces not bathed in bile acids (e.g., in the respiratory and genital tracts), lack the 0-specific polysaccharide but instead VOL. 7, 1994 on January 4, 2018 by guest Twelve to 13 different types of LOS, known as immunotypes, have been defined among N. meningitidis isolates and characterized by using monoclonal antibodies (85, 213) . Immunotypes are used to complete the serotyping system described above, and the complete serological classification of a meningococcal isolate includes the polysaccharide serogroup, the class 2/3 protein serotype, the class 1 protein subtype, and the LOS immunotype (66) . In parallel with this typing system, the meningococci can also be divided into electropherotypes by multilocus enzyme electrophoresis (36, 179, 192, 226) . Electropherotype typing examines electrophoretic differences in 10 to 15 enzymes required for bacterial growth. The electropherotypes have been grouped in clones and clusters or electropherotype complexes (222, 223) . This type of analysis has revealed that the genetic diversity of N. meningitidis is greater than that of any other bacterial species analyzed to date by this method, although the serogroup A isolates are relatively homogeneous. The distribution of serotypes and electrophoretic patterns of OMPs from different strains seem not to be related to the clonal genetic structure of the population (36) . The most recent method for characterizing meningococcal isolates is based on the restriction fragment length polymorphisms within the PCR products of the porA gene, which encodes the class 1 OMP (108). Use of this method confirms the great diversity displayed by N. meningitidis B isolates.
The LOS from Neisseria strains are composed of one to six components separable by SDS-PAGE; their relative molecular masses have been estimated to be between 3.15 and 7.10 kDa (111) . The heterogeneous electrophoretic mobility of the LOS components principally reflects differences in OS chemical composition, which also accounts for the antigenic differences. The OS structures of some strains have now been shown to be bi-or triantennary structures with 2-keto-3-deoxy-D-mannooctulonic acid linked to lipid A at the reducing end and to contain eight to ten sugar units with various amounts and localization of phosphoethanolamine ( Fig. 1) . At the nonreducing end of the longest antenna, eight of the immunotypes have a structure present in the glycosphingolipids of the paragloboside series which is a precursor of the human blood group antigens: lacto-N-neotetraose (LNnT) (133, 204) . This structure is polysialidated in human cell membranes, and the meningococcal species that produce sialic acid (serogroups B, C, W, and Y) also sialidate LNnT of their LOS (83, 160, 232) . Three of the LOS immunotypes are prevalent (in decreasing order): L3,7,9, L2, and Li containing the first two LNnT that have not been shown to be immunodominant in L3,7,9 (212) . Due to progress in organic chemical syntheses, it has been possible to prepare different structures that mimic the internal epitopes of these prevalent immunotypes, eliminating LNnT (210) .
With respect to possible vaccine preparation, only the OS have generally been considerated adequate for this purpose since lipid A is responsible for inducing septic shock (168, 210 (214) .
The latest studies on OS conjugate vaccines have given contradictory results (85, 214) . By using an OS lacking LNnT, which was derived from a group A N. meningitidis strain and conjugated to tetanus toxoid (85) , rabbit antisera with bactericidal activity against the homologous A strain (L8,10,11) and against two other strains that share the L8 epitope were obtained, although bactericidal activity for the last two strains was low. From another study in which OS from two prevalent immunotypes, L3,7,9 and L2, were used with different carriers, one can conclude that it would be difficult, if not impossible, to induce anti-LOS bactericidal antibodies against the most prevalent immunotypes in a heterogeneous population by using this type of conjugate (214) .
Lip, Pili, and CtrA In addition to OMPs, IRPs, and LOS, other noncapsular surface antigens considered possible candidates for a vaccine have been Lip, the pili, and CtrA. Lip is a surface antigen common to all pathogenic Neisseria species but absent in nonpathogenic ones. This antigen, initially designated H.8 (25) , is a lipoprotein with a molecular mass of 18 to 30 kDa. Antibodies to Lip recognize both continuous and conformational epitopes, but none have the capacity to promote complement-mediated bactericidal activity (26, 203) .
The pili are superficial appendages that N. meningitidis organisms express on mucosal surfaces, and they facilitate binding of the organism to host cells (196, 217, 218) . The main components of the meningococcal pili are repetitive polypeptides called pilins, which contain epitopes common to both meningococci and gonococci. These common epitopes are not generally immunogenic after infection, probably because they are inaccessible in the assembled pili of these organisms.
Another alternative to the capsular antigen, but closely related to it, has been identified through studies on expression and translocation mechanisms of N. meningitidis B capsular polysaccharide. It is an OMP designated CtrA which forms part of a complex system of capsular transport (70) (43) . The vaccine components are purified OMPs enriched with a complex of high-molecular-mass (65 to 95 kDa) proteins which have not been characterized (239) . The complex is noncovalently bound to the N. meningitidis C capsular polysaccharide, is aluminum hydroxide absorbed, and contains approximately 1% LOS. In the Cuban trial, the global efficacy was 80%, while in Sao Paulo, where the case control efficacy study was carried out for different age groups, this efficacy reached 74% in children older than 4 years and decreased dramatically in younger ones.
Trials have been undertaken in Norway with an OMVderived vaccine from strain B:15:P1.7,16 prepared by deoxycholate extraction (27, 173) . The preparation contained class 1, 3, and 5 OMPs absorbed on aluminum hydroxide and other minor protein components. This vaccine contained 8% LOS and 12% deoxycholate but no substantial amount of meningococcal polysaccharide. A large proportion of the bactericidal antibodies stimulated by this vaccine seemed to have been directed against protein Sc (174), whereas opsonic activity was induced against meningococcal strains that were nontypeable and had class 3 OMP (86). The vaccine efficacy among children 12 to 16 years of age was only 57%, which was considered too low for general use of the vaccine (27) .
A limitation of OMV as a vaccine against N. meningitidis B is that the protection induced is serotype or subtype specific (214) . Although some associations between certain serotypes and subtypes in epidemic outbreaks in particular areas have been established, during periods of low incidence the diseasecausing strains are heterogeneous and an important percentage are not serotypeable (18, 107, 205 (179) .
In order to achieve broad protection for a particular geographic area, the vaccine should contain 5 to 10 different OMPs (214 (129) .
The specific roles played by IgAl and the IgA proteases in the pathogenesis of mucosal infections are not yet clear. The secretory immunoglobulins (IgA) still act as a first line of host mucosal defense, interfering with cell adhesion and microbial colonization (87) . IgA has antibody-dependent antibactericidal activity mediated by monocytes in the absence of added complement (130, 157) . Through this Fca-dependent mechanism, the ability of local monocytes and macrophages to limit bacterial multiplication in mucosal tissues may be promoted, thereby decreasing the opportunity for systemic invasion by pathogenic strains. On the other hand, an excretory function has also been attributed to IgA (139, 140) . Active transport of IgA immune complexes by epithelial mucosal cells via transcytosis from the basal surface to the apex is mediated by the polymeric immunoglobulin receptor whose outer domain makes up the secretory component (116, 145) . This seems an important and efficient mechanism of antigen exclusion from the systemic circulation (104) and could also operate to exclude different pathogens, including capsulated bacteria (Fig. 2) One of the commonest procaryotic outer cell surfaces is the capsule, a very highly hydrated structure that can protect the cell against desiccation and form an outer barrier to bacteriophages, toxins, and antibacterial agents (81) . The physicochemical characteristics of the capsule constitute a clear advantage for capsulated cells in their natural environment (23) . The majority of gram-negative bacterial capsules are made up of negatively charged hydrophilic polysaccharides (24) . The N-acetyl neuraminic acid (NeuNAc) forming a part of different polymers is a structure present in the capsule of several bacteria (46) . Apart from serogroup B, it is present in groups C, Y, and W135 of N. meningitidis, in E. coli K9 and K92, and in types I, II, and III of the group B streptococci. The N. meningitidis B capsule is made up of a 200-residue homopolymer of NeuNAc in a(2-8) linkage (polyox2-8NeuNAc) (88, 125, 162) . This structure is both chemically and immunologically indistinguishable from that encountered in the capsule of E. coli Kl (105) , an important cause of meningitis in newborns (30, 112, 169, 183) . It is also present in Pasteurella haemolytica serotype A2, an important veterinary pathogen (4), as well as in Moraxella nonliquefaciens, a normally nonpathogenic commensal recovered in about 17% of human nasal specimens (32, 46) . Vaccines based on polya2-8NeuNAc would have the unique advantage of being based on an epitope present in all N. meningitidis B and E. coli Kl strains (94) .
This structure is also present on the surface of animal cells, where it has been proposed to act as a plasticity marker (177) . The neural cellular adhesion molecule (NCAM) is a membrane glycoprotein that can promote cell-cell adhesion via a homophilic binding mechanism (178) . The molecule is present in various forms differing in carbohydrate content. A highly sialidated form which is prevalent in embryonic and newborn brains exists and is gradually replaced by a less sialidated form during development. Antibodies against the N. meningitidis B capsule also recognized the highly sialidated form of NCAM (60, 66) .
One of the models proposed to explain the characteristic adhesion-regulatory properties of polya2-8NeuNAc is that of occurrence through simple physical steric hindrance mechanisms and by charge repulsion, which regulates the intercellular space. Polyct2-8NeuNAc will increase the space between different cell membranes, diminishing the levels of binding between their receptors (1, 178, 233) . Changes in the length of the polya2-8NeuNAc in NCAM modulate the adhesion properties of this molecule during embryonic development (176) . Another model used to explain the adhesion properties of polya2-8NeuNAc is one of ligand recognition and participation in the transmission of intracellular signals (177, 181) . It is of,interest to emphasize here the hypothesis that specific sialic polymer binding sites are present in the brain (112) . This could explain the bacterial tropism toward this organ when this structure is present in the capsule.
Polysialidated NCAM is also present in the developing kidney and in Wilms tumor, an embryonic type of kidney tumor (118, 176) . Research on a wide range of tumors indicates that many tumors of neuroendocrine origin express polysialidated NCAM. Among these are pheochromocytoma, small-cell carcinoma of the lung, neuroblastoma, rhabdomyosarcoma, pituitary tumors, teratomas, and medullary carcinoma of the thyroid (151, 176) . However, it is difficult to assign a general role for polyax2-8NeuNAc as having both invasive and metastatic tumor potential since many highly invasive human tumors which do not exhibit this surface marker exist, although the marker is also present in certain normal adult tissues. Polya2-8NeuNAc seems to be widely distributed in the adult rat brain, as much associated with NCAM as with the voltage-dependent sodium channel a-subunit (241) . Nevertheless, under certain conditions, polya2-8NeuNAc together with a variety of other factors could contribute to potentiate invasive growth and tumor metastasis (176) .
The view that a polya2-8NeuNAc-based vaccine could initiate autoimmune processes due to the presence of this structure in NCAM (61) polya2-8NeuNAc-specific antibody (9, 30) . The absence of detectable autoimmune disease in a patient having a monoclonal gammopathy with extremely high levels of IgM specific for polyox2-8NeuNAc, and which cross-reacted with denatured DNA and polynucleotides (73, 102, 103) , is another argument in favor of anticapsular vaccine developmental efforts. (Fig. 3) . In contrast, the polysialyl transferase activity (SiaB, now SiaD [55a]) assigned to the 54.4-kDa protein, which polymerizes CMP-NeuNAc to form polyoa2-8NeuNAc, is associated with the bacterial inner membrane. In addition, undecaprenol has been described as the acceptor molecule needed for polymerization (137) . No enzymatic activity has been assigned to the 38-kDa protein.
The B and C regions of the capsule gene complex are implicated in transport (67, 68) . The capsules of gram-negative bacteria appear to be bound to a lipidic moiety which probably acts as a hydrophobic anchor in the outer bacterial membrane (193) . In N. meningitidis B, a phospholipid covalently bound to the reducing end has this function (79, 186a) . This phospholipid presumably acts also to anchor the polysaccharide to the inner membrane (67) , a process considered fundamental in translocation, and its incorporation into the polysaccharide seems to be mediated by the B region. This region codes for two proteins with molecular masses of 45.1 and 48.7 kDa designated LipA and LipB according to their putative function of phospholipid incorporation (71) .
The C region directs the transport process itself (67) . This region codes for four proteins with molecular masses of 41, 42, 30, and 25 kDa: CtrA, CtrB, CtrC, and CtrD, respectively.
CtrA is located in the outer membrane and has a structure similar to that present in other proteins that have porin function (70) . It has hence been proposed that CtrA may form a pore in the outer membrane through which the mature capsular polysaccharide can pass (67) . CtrB and CtrC are inner membrane proteins (67, 68) , and it seems unlikely that they form a pore in the inner membrane through which polysaccharide can pass from the cytoplasm to the periplasm. Rather, these proteins could work by an active transport mechanism such as the "flippase" (71, 90) .
Regulatory functions in capsule expression have been assigned to the D and E regions (67) . Preliminary evidence indicates that these regions may participate in LOS biosynthesis and assembly.
Capsule Structure
In contrast to its chemical composition and biological activity, little is known regarding the formation and structural organization of the assembled macromolecules that make up the capsule in live bacteria. This lack of understanding is due mainly to the biophysical properties of the capsule which have given rise to a series of technical drawbacks in its study. More than 95% of the capsule is water (23) , and this hydrated nature makes it difficult to examine capsules by electron microscopy. Upon embedding and dehydration, the capsular polymers collapse easily. Various stabilizing procedures have been devised to avoid this structural collapse. Among the most widely used are stabilization via cationic charges, the use of anticapsular antibodies, and cryofixation followed by freeze substitution.
Cryofixation instantly freezes the capsular polymers in their fully hydrated and extended state, and during substitution, water is slowly replaced by organic solvent (81) . By this technique, the capsule of E. coli Ki has been observed to consist of two layers, an inner and an outer one (10) . The fibrous material of the inner layer forms a dense stratum which is probably made up of a series of thick bundles set perpendicular to the outer membrane surface. The outer layer is made up of a netlike assembly of randomly oriented fine fibers. The complete capsule is about 10 nm thick. This thickness is notably less than that of other capsules: e.g., Klebsiella pneumoniae, with a similar layout, is about 160 nm thick (10) . However when the E. coli Kl capsule was stabilized with antibodies, much higher values for the capsular thickness were obtained, i.e., >300 nm (115) . The phenomenon of capsular swelling with specific antibody treatment has long been known (23, 141) , but it is difficult to explain this 30-fold difference solely in these terms. At present, no electron microscopic data exist regarding the N. meningitidis B capsule, and possible extrapolation of E. coli Kl data should be made with caution.
The capsule in vivo is heterogeneous due to its capacity to absorb a variety of ions and macromolecules. The influence of divalent cations in the recognition of polyoa2-8NeuNAc by specific antibodies can be shown by hemagglutination assays, using purified polya2-8NeuNAc as a sensitizer. The addition of Ca2+ (0.1 M CaCl2) to the assay buffer can block the hemagglutination of erythrocytes sensitized with a polyot2-8NeuNAc-specific monoclonal antibody (52a). The influence of divalent cations in epitope expression has also been shown in LOS (82) .
Although the capsule seems to be a uniform structural entity, it is probable that a mixture of capsular material and LPS is produced (23) . In fact, the formation of 0 antigencapsular polysaccharide complexes in E. coli KI by noncovalent interactions has been described (153 ribbonlike structures (106) , which could constitute the backing over which dense fibers of the inner layer of the E. coli Kl capsule are laid down. In addition, during purification of capsular material, polysaccharide and nucleic acid were observed in close association (23) . By using capsular polysaccharide purified from N. meningitidis B cultures at different growth times (48) to sensitize erythrocytes, a correlation was established between the nucleic acid content of purified polysaccharide and the capacity to inhibit hemagglutination by an antipolya2-8NeuNAc horse polyclonal serum (9, 52a) (Fig. 4) . It has long been known that RNA, being an acidic molecule, can bind noncovalently to other acidic molecules via divalent cations to form stable complexes (78) . On the other hand, high-molecular-weight polyphosphates (200 residues long) are found closely bound to the surface of different Neisseria species (202) . Hence, nucleic acids as well as polyphosphate, which has high affinity for divalent and trivalent cations, could act as capsular backing through interactions with polya2-8NeuNAc and mediated by the divalent cations.
Barrier Function
Evidence obtained from studies with other bacteria indicate that the capsule may not function as a barrier in immune reactions with the cell surface (141) , but this is an improbable generalization. For some organisms, the capsular polysaccharide seems to function as a physical barrier whose presence could impede access by phagocytes to opsonic fragments bound to subcapsular structures (135) . In fact, there is much evidence to suggest that the E. coli Kl and N. meningitidis B capsules play such a role.
The E. coli Ki capsule seems to block both agglutination by anti-O antibodies (198, 216) and direct binding of antibodies to the internal LPS core (76, 188) . In N. meningitidis B, the capsule blocks agglutination by wheat germ agglutinin, which is specific for N-acetylglucosamine present in LOS (62) . In N. meningitidis B isolates from cerebrospinal fluid, the epitope of the OMP P3.15 is observed to be poorly marked by specific antibodies on electron microscopic examination (221) . This suggests steric hindrance by other surface molecules, the capsule being an obvious candidate.
However, the best evidence for barrier function comes from the capsule's inherent capacity to block the alternative complement pathway. Many studies have shown that the N. meningitidis B capsule, like the E. coli Kl capsule, is an important virulence factor (5, 112, 138) . In the absence of antibodies, the ability of N. meningitidis B to activate the alternative pathway is a function of its cell-associated sialic acid capsule, which impedes bactericidal activity (93) . Specific
Role of Anticapsular Antibodies in Protection against Infection
It has been postulated that antibodies to the N. meningitidis B capsule will not be protective in humans because they do not induce bactericidal activity in the presence of homologous complement (237, 239) . In contrast, when passive protection models are employed, mouse monoclonal antibodies to the capsule are clearly protective against N. meningitidis B infection (122, 169) . This is so even though recent experiments using a complement fixation microassay (51) show that mouse monoclonal antibodies fail to lyse polya2-8NeuNAc-sensitized erythrocytes in the presence of homologous complement (52a). However, in a chicken embryo model, absorption with polya2-8NeuNAc of antisera prepared by hyperimmunization with different N. meningitidis B serotypes completely eliminates the protective activity (63) . In view of these data, what mechanism(s) may be implicated in protection by anticapsular antibodies?
First, we should consider the role of anticapsular antibodies in N. meningitidis B phagocytosis. The relative importance of serum bactericidal activity in relation to neutrophil-mediated meningococcal destruction has not been precisely defined (123, 175) . It has been shown that nonimmune human serum has the capacity to opsonize N. meningitidis B cells, which in turn are phagocytized by polymorphonuclear leukocytes (175, 225) . Both antibodies and complement are needed for this process, and although the specificity of the antibodies has not been conclusively demonstrated, data exist that point directly to the capsule. The need for activation of the classical pathway for both opsonization and phagocytosis, as well as the demonstration of C3 deposition on the capsular surface (225) , suggests that the C3 deposition is mediated by anticapsular antibody activation of the classical pathway. In addition, the efficiency and kinetics of opsonization are similar in different strains independent of serotype (225) , and the presence of low titers of anticapsular antibodies in most adults has been described (121, 124, 237) . This mechanism, dependent on the classical pathway and phagocytes, can function at low antibody titers and is probably sufficient to prevent dissemination of the infectious inoculum.
Above a critical threshold of anticapsular antibodies, a second mechanism is brought into play: subcapsular C3 deposition dependent on anticapsular antibody. This deposition is mediated by the alternative pathway due to the effect described above of inactivation of the anticomplementary capacity of the capsule by anticapsular antibodies (93 An obstacle to the study of the polya2-8NeuNAc-antipolyoa2-8NeuNAc interactions has been the difficulty in obtaining specific antisera and monoclonal antibodies (69, 148) , although at present IgM (142, 148, 169, 237) and IgG (69, 194) monoclonal antibodies are both available. The traditional concept of antibody recognition of polysaccharide antigens whereby only six or seven residues are needed to form the antibody binding epitope (14, 101, 155) is not in agreement with known data regarding polyot2-8NeuNAc-anti-polyot2-8NeuNAc interactions (89, 99, 124) .
The conformation of a linear homopolymer of a single sugar joined by a single type of glycosidic linkage is determined by the linkage which controls the position of each sugar ring in relation to the adjacent bound residues (167). The repetitive nature of the linkage pattern results in the regular, periodic structure of the polymer. Many studies have been carried out to try to determine the three-dimensional structure of polyot2-8NeuNAc by nuclear magnetic resonance. There are studies that suggest that the polymer adopts a permanent helical structure in solution (231) . Others, however, postulate that the predominant conformation of polysaccharide in solution is a random coil with only the occasional presence of an extended helical structure (35) , the epitope recognized by anti-polyct2-8NeuNAc antibodies.
Smaller OS of the same repetitive structure can completely inhibit antibody binding to the native polysaccharide at high concentrations (99, 166, 194) , and it is even possible to inhibit this binding with NeuNAc (49, 166) , indicating that the same antibodies bind to antigens smaller than the native polysaccharide, although with lower affinity. The presence of conformational epitopes could explain how a specific antibody response to a polysaccharide with repetitive structural units identical to host OS could be obtained even though cross-reactions between antipolysaccharide antibodies and host antigens are not produced (229) . This situation occurs with sialogangliosides and sialoglycoproteins containing short chains of NeuNAc bound by a(2-8) linkages that are ubiquitous on host cell surfaces (124) , but this explanation does not eliminate the possibility of cross-reactivity with the long-chain polya2-8Neu-NAc present in NCAM in vivo.
In addition to the conformational requirements, another type of restriction exists in the interaction between polya2-8NeuNAc and its specific antibodies, i.e., temperature. Antipolyot2-8NeuNAc antibodies show markedly reduced avidity when the temperature is increased from 4 to 37°C (134) . This difference in avidity is still considerable for reactions at temperatures over a shorter range, e.g., between 22 and 370C (184) . The decrease in avidity at 37°C can be translated into an antigen concentration dependence on antibody binding (50) . Only surfaces with a high polyoa2-8NeuNAc density, like N. meningitidis B or E. coli Kl capsules, are recognized by the specific antibody at 37°C, whereas in vivo, host cells with this structure do not fulfill these recognition requirements. The polya2-8NeuNAc of NCAM could, however, be recognized by in vitro assays carried out at room temperature or 4°C (1, 60, 61). 
Strategies To Increase Response
In general, the immune response to purified polysaccharide is thymus independent; IgM antibodies are produced, and no increased response is observed on hyperimmunization (53, 124) . In contrast to the majority of capsulated bacteria, E. coli Ki and N. meningitidis B capsules are poorly immunogenic whether administered as formalin-inactivated organisms or as purified polysaccharide (51, 154) . It is possible, however, to obtain high-titer anticapsular antisera in horses by repeated immunization with formalinized N. meningitidis B (9) .
The immune response to a polysaccharide can also be increased by injecting it (or its constituent OS) coupled covalently to protein carriers (53, 124, 132) . This process generally transforms the antigen from a thymus-independent to a thymus-dependent one, resulting in a stronger response than to the polysaccharide alone. It also gives rise to IgG antibodies and memory cells, as has been demonstrated for the meningococcal group A and C capsular polysaccharides (41), H. influenzae type b (12), pneumococcus (161, 215) , or the group B streptococcus (119, 159) .
Tetanus toxoid has been among the most frequent protein carriers used to prepare polyao2-8NeuNAc conjugates with whole polysaccharide (97) or derived OS (165) . In spite of this approach to convert the N. meningitidis A and C conjugates into T-dependent immunogens and thus to obtain high titers of specific antipolysaccharide antibodies, the immunogenicity of polya2-8NeuNAc was not increased. The optimal carriers for increasing the anticapsular response in conjunction with unmodified polya2-8NeuNAc are the OMPs, which form a noncovalent complex with the polya2-8NeuNAc probably across the lipid moiety of the polysaccharide (143) . This is the case even though different coupling methods can give rise to a variable polysaccharide response (64, 127, 238) . Although it is possible to obtain high titers of specific polya2-8NeuNAc antibodies in mice immunized with the OMP complex, the antibody is restricted to the IgM isotype (49, 126, 143) (Fig. 5) . The complex has been shown to protect mice (143) against N. meningitidis B and newborn rabbits whose mothers were immunized with complex against E. coli Kl (123) . In humans, the anti-polya.2-8NeuNAc antibodies obtained with the complex were biologically active in a mouse passive protection model (126) .
Another strategy to improve the immunogenicity of polyao2- N-acetyl groups of the NeuNAc residues with N-propionyl groups, leaving the specific antigenicity unaltered (98) . Al (20, 95, 96) .
A final approach to elicit anticapsular antibodies against N. meningitidis B is to use polysaccharides with similar structures. Cross-reactivity between N. meningitidis and N. lactamica led to the proposal that antigenically similar capsules existed in both organisms (136) . However, further studies invalidated this hypothesis and demonstrated that the cross-reactivity was derived from an epitope present in the LOS (110) . The most promising work in this direction has been carried out with E. coli K92. Its capsule is a homopolymer of NeuNAc linked alternately a(2-8) and a(2-9) (128), and this structure has been used before to induce antibodies to the N. meningitidis C capsule (77 (11, 54) .
For an antigen to be considered a vaccine candidate for the entire serogroup B, two fundamental requirements must be fulfilled: it must be highly conserved among the different strains, and it must induce bactericidal antibodies. The latter is of particular importance in protection against N. meningitidis (191) . To 
